Endogenous glutamine decrease is associated with pancreatic cancer progression

Pancreatic ductal adenocarcinoma (PDAC) is becoming the second leading cause of cancer-related death in the Western world. The mortality is very high, which emphasizes the need to identify biomarkers for early detection. As glutamine metabolism alteration is a feature of PDAC, its in vivo evaluation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Roux, Cecilia, Riganti, Chiara, Borgogno, Sammy Ferri, Curto, Roberta, Curcio, Claudia, Catanzaro, Valeria, Digilio, Giuseppe, Padovan, Sergio, Puccinelli, Maria Paola, Isabello, Monica, Aime, Silvio, Cappello, Paola, Novelli, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707027/
https://ncbi.nlm.nih.gov/pubmed/29221133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados